Gilead’s Sponsored Link For Viread Can’t Prevent Trouble With FDA

Agency cites firm for unapproved claim, not including any risk information, and not submitting link to FDA.

FDA gave another indication of what its forthcoming social media guidance on sponsored links will look like in citing Gilead Sciences Inc. for its Viread (tenofovir disoproxil fumarate) link.

In a June 27 letter, FDA’s Office of Prescription Drug Promotion objected to the “Hepatitis B Prevention” claim...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from United States

More from North America